Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications*; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales
D014151:Anti-Anxiety Agents; D010919:Placebos; D008140:Lorazepam